Company / Revenue
Integra Lifesciences Holdings Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.6B
FY2025
5-year range
$1.5B / $1.6B
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#85 of 156
Health Care
What the data says
At $1.6B, Integra Lifesciences Holdings's revenue ranks #85 of 156 in the Health Care sector. Revenue has fluctuated over the past 10 years, ranging from $797M in FY2016 to $1.6B in FY2025.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +3.6%.
Improved from $1.5B to $1.6B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#85 of 156 in Health CareTop 54% of 156This company $1.6B Sector average $19.0B
▼
-91.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, revenue increased 1.5% year-over-year.
- Ranks #85 out of 156 companies in the Health Care sector.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +1.5% |
| FY2024 | $1.6B | +4.5% |
| FY2023 | $1.5B | -1.0% |
| FY2022 | $1.6B | +1.0% |
| FY2021 | $1.5B | +12.4% |
| FY2020 | $1.4B | -9.6% |
| FY2019 | $1.5B | +3.1% |
| FY2018 | $1.5B | +66.8% |
| FY2017 | $882.7M | +10.8% |
| FY2016 | $796.7M | -9.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026